Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial

Yao, J; Guo, XH; Sun, L; Han, P; Lv, XF; Zhang, XZ; Mo, ZH; Yang, WY; Zhang, LH; Wang, ZJ; Zhu, L; Li, QM; Yang, T; Wang, WB; Xue, YM; Shi, YQ; Lu, JM; Peng, YD; Zhang, F; Yan, DW; Wang, DM; Yu, XF

Guo, XH (通讯作者)，Peking Univ First Hosp, Dept Endocrinol, 8 Xishiku St, Beijing 100034, Peoples R China.

CURRENT MEDICAL RESEARCH AND OPINION, 2022; 38 (11): 1797

Abstract

Objective This phase 3 confirmatory diabetes mellitus treatment study compared the safety and efficacy of Rapilin and NovoRapid insulin asparts in com......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索